abstract |
The present invention relates to compounds having the general formula (I) depicted below, useful for inhibiting HIV protease. The present invention also relates methods of making such compounds, and their use as therapeutic agents, for example, in treating wild-type HIV and of multidrug-resistant strains of HIV. (see formula I) |